MICHELLE DALTON: Open Payments
NPI 1225736499 · PALOS PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 58 payments from 17 companies in 2025. Trend: 2023 $592 · 2024 $1,521 · 2025 $1,554
Food & beverage: $1,554
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $258 |
| Edwards Lifesciences Corporation | 3 | $220 |
| Amgen Inc. | 8 | $159 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $108 |
| PFIZER INC. | 4 | $98 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $92 |
| Chiesi USA, Inc. | 3 | $66 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, REPATHA, SPRAVATO, TRYVIO, Epclusa, VYNDAQEL, LifeVest.
Industry payments across IL — which companies pay providers there.
